Smurfit Westrock (SW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jan, 2026Executive summary
Net sales reached $7.656 billion in Q1 2025, with adjusted EBITDA of $1.252 billion and a 16.4% margin, reflecting robust growth from the Smurfit Kappa–WestRock combination and synergy realization.
North America showed significant structural improvement and margin gains, EMEA & APAC remained resilient, and LATAM delivered robust results, all supported by ongoing integration and cost actions.
Synergy program is on track, with $80 million delivered in Q1 and a $400 million run-rate expected by end of 2025.
Announced closures of over 500,000 tons of paper capacity and several converting facilities in the US, Germany, Mexico, and the Netherlands to optimize the asset base.
Investments in new converting plants and cost take-out projects are underway across all regions.
Financial highlights
Q1 2025 net sales: $7.656 billion; adjusted EBITDA: $1.252 billion; adjusted EBITDA margin: 16.4%.
Net income: $382 million; net income margin: 5.0%; diluted EPS: $0.73.
Gross profit: $1.577 billion; operating profit: $553 million.
Segment net sales: North America $4.7B, EMEA & APAC $2.6B, LATAM $0.5B.
Adjusted EBITDA up from $475 million in Q1 2024, with margin improvement year-over-year.
Outlook and guidance
Q2 2025 adjusted EBITDA expected at approximately $1.2 billion; full-year 2025 guidance for adjusted EBITDA between $5.0 billion and $5.2 billion.
Additional $100 million of economic downtime expected in Q2, primarily a one-off event.
Capital expenditure for 2025 projected at $2.2–$2.4 billion.
Board approved a quarterly dividend of $0.4308 per share, payable June 18, 2025.
Demand outlook remains uncertain, with focus on profitability and synergy capture.
Latest events from Smurfit Westrock
- Targets $7bn Adjusted EBITDA and ~19% margin by 2030, with strong capital returns and global growth.SW
Investor presentation11 Mar 2026 - 2025 saw robust results, strong governance, and key proposals for shareholder approval.SW
Proxy Filing11 Mar 2026 - AGM to vote on directors, compensation, auditor, and share issuance; board recommends approval.SW
Proxy Filing11 Mar 2026 - Q4 net sales $7.58B, $4.94B Adjusted EBITDA; 2026 EBITDA guidance $5–$5.3B.SW
Q4 202511 Feb 2026 - Merger creates global leader; Q2 net income falls, but integration and synergies drive outlook.SW
Q2 20242 Feb 2026 - Q3 sales hit $7.7B, Adjusted EBITDA $1.27B, but one-time costs led to a $150M net loss.SW
Q3 202417 Jan 2026 - Q4 net sales $7.5B, $1.17B EBITDA, $400M synergies, and 42% dividend increase achieved.SW
Q4 20248 Jan 2026 - Shareholders to vote on directors, executive pay, auditor, and key governance proposals.SW
Proxy Filing2 Dec 2025 - AGM to vote on directors, executive pay, auditor, and key share issuance proposals.SW
Proxy Filing2 Dec 2025